Advertisement
UK markets close in 3 hours 45 minutes
  • FTSE 100

    8,090.10
    +49.72 (+0.62%)
     
  • FTSE 250

    19,709.08
    -10.29 (-0.05%)
     
  • AIM

    755.29
    +0.60 (+0.08%)
     
  • GBP/EUR

    1.1670
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2510
    +0.0048 (+0.39%)
     
  • Bitcoin GBP

    51,052.19
    -2,144.27 (-4.03%)
     
  • CMC Crypto 200

    1,356.87
    -25.70 (-1.86%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.98
    +0.17 (+0.21%)
     
  • GOLD FUTURES

    2,340.60
    +2.20 (+0.09%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,957.59
    -131.11 (-0.72%)
     
  • CAC 40

    8,013.31
    -78.55 (-0.97%)
     

Global Sterile Filtration Market Report 2021-2026 - Bioburden Control in a Booming Biopharmaceutical Industry Spells Opportunity for Sterile Filtration

Dublin, Nov. 09, 2021 (GLOBE NEWSWIRE) -- The "Sterile Filtration - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Global Sterile Filtration Market to Reach $7.3 Billion by 2026

Amid the COVID-19 crisis, the global market for Sterile Filtration estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$7.3 Billion by 2026, growing at a CAGR of 7.2% over the analysis period.

Cartridge Filters, one of the segments analyzed in the report, is projected to grow at a 6.9% CAGR to reach US$2.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Capsule Filters segment is readjusted to a revised 7.7% CAGR for the next 7-year period. This segment currently accounts for a 26.4% share of the global Sterile Filtration market.

Sterilization and filtration is gaining increasing importance across multiple industries owing to the burden of compliance. Hitherto the pharmaceutical/biological and food & beverage industries were the primary users of sterilization systems. Even within the food & beverage industry, the focus on sterilization and prevention of containment have become prime focus areas owing to a string of contamination issues across the world. In such a scenario, provision of contaminant-free food/beverages has emerged as a key trend. Hitherto, heat was the primary mode of sterilization.

ADVERTISEMENT

However, many factors such as loss of product characteristics, and high costs of energy are driving food processors to migrate to sterile filtration. In addition, many products such as biopharmaceuticals are not suitable for heat sterilization, leading to increasing use of membrane filters. Even in the food & beverage industry, sterile filtration is gaining increasing acceptance owing to lower process time and costs.

The market is expected to benefit from increased production of biologics. In the pharmaceutical sector, the biotherapeutics is one of the most rapidly growing segments. Key factors driving the growth of biotherapeutics market include the capability to treat diseases that were earlier untreatable. In addition, biotherapeutics are known for its safety and efficiency. There are several other factors stimulating the biotherapeutics market growth.

For instance, technological developments in several associated fields is leading to the development of large collection of plausible drug targets and also considerable progress in the perception of diseases. Furthermore, the synthesis of human insulin and Monoclonal Antibodies (MABs) are also factors helping to propel the biotherapeutics market growth. The existing scenario in the field of biologics is set to drive growth of biotherapeutic medicines in the near term. The number of biotech patents applications continues to increase by around 25% annually.

The biological drugs industry is increasingly focusing on sterile filtration to achieve contaminant-free products. Drugs are highly heat sensitive and filtration plays a key role in ensuring the integrity of these drugs. In addition, there is an increasing focus on bioburden by both regulators and companies as contamination of drugs poses high risks for patients, including fatal risks.

From a manufacturer point of view, contamination also includes financial risk as closure of plants could lead to losses in billions of dollars. Moreover, the collateral damage to reputation could and remedial measures from regulators could also severely affect the companies. Even if a batch of drugs does not pass the quality parameters, the lost opportunity in terms of market and financial losses are very high. Sterile filtration therefore plays a significant role in the biopharmaceutical industry as an effective method for sterilizing products.

It can be technically very challenging to terminally sterilize biopharmaceutical products, making it vital to use sterilizing-grade filtration for such aseptic processing applications. Heat sterilization, or any other method requiring an input of energy into biotechnology drug products, can cause unwanted degradation to the product, which can only be prevented through the use of sterilized filtration.

Sterilizing membrane filtration as a method for physically removing microbes from heat-sensitive biopharmaceutical fluids has been practiced for several decades, and there is already a high level of expertise and experience in the industry. The process has been well understood and has proved itself to be reliable when validated properly.

Sterile filtration is also commonly required for reducing the levels of bioburden within process streams for avoiding the potential formation of a biofilm. Process validation of sterilizing-grade filters is an essential task for ensuring and verifying the filter`s performance within the fluid stream and process conditions.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Importance of Sterile Resources in Various Manufacturing Processes: A Primer

  • These are Times When Questions Abound & Answers Are Few

  • So How Fast Or Slow Are We Moving?

  • India's Second Wave Makes It Clear That Equity is Not a Part of Global Policy on Tackling COVID

  • Progress on Vaccinations, Why Should Businesses Care?

  • With IMF's Upward Revision of Global GDP Forecasts for 2021, Most Companies Are Bullish About a Global Economic Comeback

  • A Retrospective Review of Year 2020 as the Worst Year in Humanity's History that Left the World in Shambles & Industries and Markets Upended

  • What is Sterile Filtration & Why Is it Important in Food & Pharma Industries?

  • Recent Market Activity

  • World Brands

2. FOCUS ON SELECT PLAYERS (Total 40 Featured)

  • 3M Company

  • General Electric Company

  • Merck KgaA

  • MilliporeSigma

  • Pall Corporation

  • Parker Hannifin Corporation

  • Porvair Filtration Group Ltd.

  • Sartorius Stedim Biotech SA

  • Starlab Scientific Co., Ltd

  • Sterlitech Corporation

3. MARKET TRENDS & DRIVERS

  • Growing Biopharmaceuticals Industry Led by Rising R&D Investments Fuels Foundational Growth in the Market

  • Bioburden Control in a Booming Biopharmaceutical Industry Spells Opportunity for Sterile Filtration

  • Here's How Focus On Bioburden Control is Driving Demand for Sterile Filtration in the Biopharmaceutical Industry

  • Increase in Vaccine Production Pushes Up Need for Sterile Filtration

  • Sterile Filtration & Vaccines

  • Robust Demand for Processed Food to Benefit Demand Growth

  • Pandemic Spurs Demand for Packaged Food & Beverages

  • Why Filtration Is Essential in Food Processing & Production?

  • On Cards, Robust Growth Opportunities in the Alcohol Industry, Post Pandemic

  • Role of Sterile Filtration in Wine & Beer Production

4. GLOBAL MARKET PERSPECTIVE

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

  • Total Companies Profiled: 40

For more information about this report visit https://www.researchandmarkets.com/r/pi9lyt

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900